Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Astaxanthin in Spinal Cord Injury
IRCT20231024059828N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2023
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of astaxanthin in spinal cord injury (SCI), sponsored by Shahid Beheshti University of Medical Sciences. Started Dec 2023; status: completed.
02
Drugs
astaxanthin
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on IRCT20231024059828N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231024059828N1.